Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
365
-
Total 13F shares, excl. options
-
55,981,751
-
Shares change
-
+3,055,451
-
Total reported value, excl. options
-
$9,636,187,173
-
Value change
-
+$534,776,063
-
Put/Call ratio
-
42%
-
Number of buys
-
204
-
Number of sells
-
129
-
Price
-
$172.30
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2018
As of 30 Jun 2018 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 439 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,981,751 shares of stock of the company.
Largest 10 holders included FMR LLC, PUTNAM INVESTMENTS LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Bank of New York Mellon Corp, TIAA CREF INVESTMENT MANAGEMENT LLC, Partner Fund Management, L.P., STATE STREET CORP, and Boston Partners.
This table shows 439 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.